These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31367591)

  • 21. Monte Carlo simulation of tilted contact plaque brachytherapy placement for juxtapapillary retinoblastoma.
    Nakamura S; Murakami N; Suzuki S; Ito K; Takemori M; Nakayama H; Kaga K; Chiba T; Iijima K; Takahashi K; Goka T; Itami J; Okamoto H; Igaki H
    Radiat Oncol; 2022 Jan; 17(1):16. PubMed ID: 35073956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying the effect of eccentric ruthenium plaque placement on tumor volume dose.
    Flanagan JPM; Udovenya WHF; Astrahan MA; McKay D; Phillips C; McKenzie JD; O'Day R; Fog LS
    J Contemp Brachytherapy; 2023 Dec; 15(6):442-447. PubMed ID: 38230400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
    Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
    Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified Geometry of
    Miras H; Terrón JA; Bertolet A; Leal A
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
    Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
    Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical Note: Monte Carlo study of
    Hermida-López M; Brualla L
    Med Phys; 2017 Jun; 44(6):2581-2585. PubMed ID: 28370303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monte Carlo simulation of COMS ophthalmic applicators loaded with Bebig I25.S16 seeds and comparison with planning system predictions.
    Miras H; Terrón JA; Lallena AM
    Phys Med; 2013 Nov; 29(6):670-6. PubMed ID: 22858007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of gold nanoparticle effects in brachytherapy by an electron emitter ophthalmic plaque.
    Hashemi S; Aghamiri MR; Kahani M; Jaberi R
    Int J Nanomedicine; 2019; 14():4157-4165. PubMed ID: 31239674
    [No Abstract]   [Full Text] [Related]  

  • 31. Dual-energy CT imaging of orbits during episcleral brachytherapy with Ru-106 plaques: A phantom study on its potential for plaque position verification.
    Perisinakis K; Detorakis ET; Tzedakis A; Liakopoulos DA; Papadaki E; Damilakis J
    Phys Med; 2020 May; 73():1-7. PubMed ID: 32278254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk.
    Itta F; Liuzzi R; Farella A; Porri G; Pacelli R; Conson M; Oliviero C; Buonanno F; Breve MA; Cennamo G; Clemente S; Cella L
    Phys Med; 2020 Aug; 76():285-293. PubMed ID: 32738776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the shielding effectiveness of silicone oil vitreous substitutes when used with Palladium-103 and Iodine-125 eye plaques.
    Yang YM; Chow PE; McCannel TA; Lamb JM
    Med Phys; 2019 Feb; 46(2):1006-1011. PubMed ID: 30554429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment plan optimization and robustness of
    Heilemann G; Fetty L; Dulovits M; Blaickner M; Nesvacil N; Georg D; Dunavoelgyi R
    Radiother Oncol; 2017 Apr; 123(1):119-124. PubMed ID: 28185660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of GATE Monte Carlo Code for Simulation and Dosimetry of New I-125 Seeds in Eye Plaque Brachytherapy.
    Taherparvar P; Fardi Z
    Nucl Med Mol Imaging; 2021 Apr; 55(2):86-95. PubMed ID: 33968275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measured, calculated, and egs_brachy I-125 dose distributions in a gold plaque for retinoblastoma treatment.
    Trauernicht CJ; van Eeden D; du Plessis FCP
    Med Phys; 2022 Sep; 49(9):6183-6194. PubMed ID: 35792659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A convex windowless extrapolation chamber to measure surface dose rate from
    Hansen JB; Culberson WS; DeWerd LA
    Med Phys; 2019 May; 46(5):2430-2443. PubMed ID: 30873611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
    Thomson RM; Rogers DW
    Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
    Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
    Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.